Literature DB >> 10854204

Genetic progression in the pancreatic ducts.

R H Hruban1, R E Wilentz, S E Kern.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10854204      PMCID： PMC1850064          DOI： 10.1016/S0002-9440(10)65054-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  38 in total

1.  p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.

Authors:  C A Moskaluk; R H Hruban; S E Kern
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

2.  Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

Authors:  R E Wilentz; G H Su; J L Dai; A B Sparks; P Argani; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications.

Authors:  M Goggins; R H Hruban; S E Kern
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

4.  Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas.

Authors:  D J Brat; K D Lillemoe; C J Yeo; P B Warfield; R H Hruban
Journal:  Am J Surg Pathol       Date:  1998-02       Impact factor: 6.394

5.  p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

Authors:  M S Redston; C Caldas; A B Seymour; R H Hruban; L da Costa; C J Yeo; S E Kern
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

6.  Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma.

Authors:  E Brockie; A Anand; J Albores-Saavedra
Journal:  Ann Diagn Pathol       Date:  1998-10       Impact factor: 2.090

Review 7.  K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.

Authors:  R H Hruban; A D van Mansfeld; G J Offerhaus; D H van Weering; D C Allison; S N Goodman; T W Kensler; K K Bose; J L Cameron; J L Bos
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  Morphological lesions associated with human primary invasive nonendocrine pancreas cancer.

Authors:  A L Cubilla; P J Fitzgerald
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

9.  Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark.

Authors:  O Kronborg; C Fenger; J Olsen; K Bech; O Søndergaard
Journal:  Scand J Gastroenterol       Date:  1989-06       Impact factor: 2.423

10.  Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.

Authors:  C J Yeo; J L Cameron; K D Lillemoe; J V Sitzmann; R H Hruban; S N Goodman; W C Dooley; J Coleman; H A Pitt
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969
View more
  111 in total

1.  Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis.

Authors:  N Howes; J P Neoptolemos
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

Review 2.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 3.  Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.

Authors:  André L Mihaljevic; Christoph W Michalski; Helmut Friess; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2010-03-18       Impact factor: 3.445

4.  Changes in connexin43 expression and localization during pancreatic cancer progression.

Authors:  Joell L Solan; Sunil R Hingorani; Paul D Lampe
Journal:  J Membr Biol       Date:  2012-06-23       Impact factor: 1.843

Review 5.  Emerging role of the KRAS-PDK1 axis in pancreatic cancer.

Authors:  Riccardo Ferro; Marco Falasca
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

6.  Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer.

Authors:  Peter Büchler; Howard A Reber; James S Tomlinson; Oliver Hankinson; Georgis Kallifatidis; Helmut Friess; Ingrid Herr; Oscar J Hines
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

7.  5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue.

Authors:  René Hennig; Xian-Zhong Ding; Wei-Gang Tong; Matthias B Schneider; Jens Standop; Helmut Friess; Markus W Büchler; Parviz M Pour; Thomas E Adrian
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.

Authors:  Phillippe P Gonzalez; Jungeun Kim; Rui Pedro Galvao; Nichola Cruickshanks; Roger Abounader; Hui Zong
Journal:  Glia       Date:  2018-02-02       Impact factor: 7.452

Review 9.  Precursors to pancreatic cancer.

Authors:  Ralph H Hruban; Anirban Maitra; Scott E Kern; Michael Goggins
Journal:  Gastroenterol Clin North Am       Date:  2007-12       Impact factor: 3.806

10.  Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.

Authors:  Nabeel Bardeesy; Andrew J Aguirre; Gerald C Chu; Kuang-Hung Cheng; Lyle V Lopez; Aram F Hezel; Bin Feng; Cameron Brennan; Ralph Weissleder; Umar Mahmood; Douglas Hanahan; Mark S Redston; Lynda Chin; Ronald A Depinho
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.